Beyond atopy: etiological evaluation of markedly elevated serum total IgE (>1000 IU/ml)

Year 2026, Volume: 7 Issue: 1, 154 - 159, 20.02.2026

Şeyma Özden , Arzu Karasu Çelik Fatma Merve Tepetam , Özge Atik , Bengü Kaan

https://izlik.org/JA53MY64JH

Abstract

Aims: Marked elevation of serum total immunoglobulin E (IgE) levels (>1000 IU/ml) is most commonly associated with atopic diseases; however, its underlying etiology is highly heterogeneous. This study aimed to systematically evaluate the etiological factors associated with markedly elevated serum total IgE levels in patients attending an allergy and immunology outpatient clinic.
Methods: Medical records of 1103 patients with serum total IgE levels >1000 IU/ml who presented to the allergy and immunology outpatient clinic between January 1 and September 1, 2023, were retrospectively reviewed. Patients with only a single outpatient visit and those who did not undergo adequate diagnostic evaluation to determine the cause of IgE elevation were excluded. A total of 643 patients who completed comprehensive clinical, laboratory, and diagnostic assessments were included in the final analysis. Etiological causes of IgE elevation were classified based on clinical and laboratory findings.
Results: The mean age of the 643 patients was 47.55±17.00 years, and 52.9% were female. The median serum total IgE level was 1520 (1001–62,753) IU/ml. Atopic diseases were identified as the most common etiological factor (n:530, 82.4%). Other causes included infectious diseases (5.3%), inflammatory diseases (1.2%), neoplasms (0.5%), primary immunodeficiency disorders (0.2%), drug-related causes (0.2%), and other conditions (0.2%). Despite comprehensive evaluation, no underlying cause could be identified in 65 patients (10.1%), who were classified as having idiopathic total IgE elevation.
Conclusion: Although markedly elevated serum total IgE levels are predominantly associated with atopic diseases, a substantial proportion of patients have alternative or unidentified etiologies. A systematic and multidisciplinary diagnostic approach is essential to accurately identify the underlying cause of IgE elevation and to guide appropriate clinical management.

Keywords

Total IgE , atopic diseases , etiology , hyper-IgE , allergy

References

• Ogulur I, Mitamura Y, Yazici D, et al. Type 2 immunity in allergic diseases. Cell Mol Immunol. 2025;22(3):211-242. doi:10.1038/s41423-025-01261-2
• Bachert C, Hicks A, Gane S, et al. The interleukin-4/interleukin-13 pathway in type 2 inflammation in chronic rhinosinusitis with nasal polyps. Front Immunol. 202416;15:1356298. doi:10.3389/fimmu.2024.1356298
• Galli SJ, Tsai M. IgE and mast cells in allergic disease. Nat Med. 2012; 18(5):693-704. doi:10.1038/nm.2755
• Bochner BS, Stokes J. The biology of IgE. Up to Date. 2025.
• Al-Mughales JA. Diagnostic utility of total IgE in foods, inhalant, and multiple allergies in Saudi Arabia. J Immunol Res. 2016;2016:1058632. doi:10.1155/2016/1058632
• Maizels RM, McSorley HJ. Regulation of the host immune system by helminth parasites. J Allergy Clin Immunol. 2016;138(3):666-675. doi:10. 1016/j.jaci.2016.07.007
• Agarwal R, Sehgal IS, Muthu V, et al. Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses. Eur Respir J. 2024;63(4):2400061. doi:10.1183/13993003.00061-2024
• Sutanto H, Adytia GJ, Fetarayani D. Hyper IgE syndrome: bridging the gap between immunodeficiency, atopy, and allergic diseases. Curr Allergy Asthma Rep. 2025;25(1):17. doi:10.1007/s11882-025-01196-8
• Gould HJ, Sutton BJ. IgE in allergy and asthma today. Nat Rev Immunol. 2008;8(3):205-217. doi:10.1038/nri2273
• Bousquet J, Humbert M, Gibson PG, et al. Real-world effectiveness of omalizumab in severe allergic asthma: a meta-analysis of observational studies. J Allergy Clin Immunol Pract. 2021;9(7):2702-2714. doi:10.1016/j.jaip.2021.01.011
• Nemet S, Elbirt D, Cohen R, et al. Clinical significance of very high IgE levels (≥1000 IU/ml): population-based study of 118,211 adults. J Allergy Clin Immunol Glob. 2025;4(2):100403. doi:10.1016/j.jacig.2025.100403
• Stone KD, Prussin C, Metcalfe DD. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol. 2010;125(2 Suppl 2):S73-S80. doi: 10.1016/j.jaci.2009.11.017
• Johansson SG, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol. 2004;113(5):832-836. doi:10.1016/j.jaci.2003.12.591
• Siroux V, Ballardini N, Soler M, et al. The asthma-rhinitis multimorbidity is associated with IgE polysensitization in adolescents and adults. Allergy. 2018;73(7):1447-1458. doi:10.1111/all.13410
• Cooper PJ. Interactions between helminth parasites and allergy. Curr Opin Allergy Clin Immunol. 2009;9(1):29-37. doi:10.1097/ACI.0b013e 32831f44a6
• Nutman TB. Evaluation and differential diagnosis of marked, persistent eosinophilia. Immunol Allergy Clin North Am. 2007;27(3):529-549. doi: 10.1016/j.iac.2007.07.008
• Wechsler ME, Akuthota P, Jayne D, et al. Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis. N Engl J Med. 2017; 376(20):1921-1932. doi:10.1056/NEJMoa1702079
• Vaglio A, Moosig F, Zwerina J. Churg–Strauss syndrome: update on pathophysiology and treatment. Curr Opin Rheumatol. 2012;24(1):24-30. doi:10.1097/BOR.0b013e32834d85ce
• Chen H, Thompson LD, Aguilera NS, Abbondanzo SL. Kimura disease: a clinicopathologic study of 21 cases. Am J Surg Pathol. 2004;28(4):505-513. doi:10.1097/00000478-200404000-00010
• Kelesidis T, Yang O. Good’s syndrome remains a mystery after 55 years: a systematic review of the scientific evidence. Clin Immunol. 2010;135(3): 347-363. doi:10.1016/j.clim.2010.01.006
• Holland SM, DeLeo FR, Elloumi HZ, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med. 2007;357(16):1608-1619. doi:10.1056/NEJMoa073687
• Pichler WJ. Drug hypersensitivity reactions: classification and relationship to T-cell activation. Curr Opin Allergy Clin Immunol. 2004; 4(4):313-319. doi:10.1097/00130832-200408000-00010
• Freeman AF, Holland SM. Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes. Pediatr Res. 2009;65(5 Pt 2): 32R-37R. doi:10.1203/PDR.0b013e31819dc8c5